Blueprint Medicines Statistics
Total Valuation
HNST has a market cap or net worth of $498.27 million. The enterprise value is $445.10 million.
Important Dates
The next confirmed earnings date is Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HNST has 110.24 million shares outstanding. The number of shares has increased by 8.66% in one year.
| Current Share Class | 110.24M |
| Shares Outstanding | 110.24M |
| Shares Change (YoY) | +8.66% |
| Shares Change (QoQ) | +9.24% |
| Owned by Insiders (%) | 8.51% |
| Owned by Institutions (%) | 56.85% |
| Float | 95.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 59.47 |
| PS Ratio | 1.22 |
| Forward PS | 1.22 |
| PB Ratio | 2.82 |
| P/TBV Ratio | 2.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | 1,332.62 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.17, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.17 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 3.57 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.96% and return on invested capital (ROIC) is -0.89%.
| Return on Equity (ROE) | -0.96% |
| Return on Assets (ROA) | -0.68% |
| Return on Invested Capital (ROIC) | -0.89% |
| Return on Capital Employed (ROCE) | -1.31% |
| Revenue Per Employee | $2.37M |
| Profits Per Employee | -$8,945 |
| Employee Count | 164 |
| Asset Turnover | 1.68 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, HNST has paid $90,000 in taxes.
| Income Tax | 90,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.14% in the last 52 weeks. The beta is 2.34, so HNST's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | +42.14% |
| 50-Day Moving Average | 4.79 |
| 200-Day Moving Average | 5.42 |
| Relative Strength Index (RSI) | 44.28 |
| Average Volume (20 Days) | 3,212,694 |
Short Selling Information
The latest short interest is 9.79 million, so 8.88% of the outstanding shares have been sold short.
| Short Interest | 9.79M |
| Short Previous Month | 9.44M |
| Short % of Shares Out | 8.88% |
| Short % of Float | 10.27% |
| Short Ratio (days to cover) | 3.81 |
Income Statement
In the last 12 months, HNST had revenue of $389.37 million and -$1.47 million in losses. Loss per share was -$0.02.
| Revenue | 389.37M |
| Gross Profit | 150.45M |
| Operating Income | -2.51M |
| Pretax Income | -12.36M |
| Net Income | -1.47M |
| EBITDA | 334,000 |
| EBIT | -2.51M |
| Loss Per Share | -$0.02 |
Full Income StatementBalance Sheet
The company has $72.82 million in cash and $19.64 million in debt, giving a net cash position of $53.18 million or $0.48 per share.
| Cash & Cash Equivalents | 72.82M |
| Total Debt | 19.64M |
| Net Cash | 53.18M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 180.36M |
| Book Value Per Share | 1.63 |
| Working Capital | 160.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.73 million and capital expenditures -$516,000, giving a free cash flow of -$2.25 million.
| Operating Cash Flow | -1.73M |
| Capital Expenditures | -516,000 |
| Free Cash Flow | -2.25M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 38.64%, with operating and profit margins of -0.64% and -0.38%.
| Gross Margin | 38.64% |
| Operating Margin | -0.64% |
| Pretax Margin | -0.35% |
| Profit Margin | -0.38% |
| EBITDA Margin | 0.09% |
| EBIT Margin | -0.64% |
| FCF Margin | n/a |
Dividends & Yields
HNST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.66% |
| Shareholder Yield | -8.66% |
| Earnings Yield | -0.29% |
| FCF Yield | -0.45% |
Analyst Forecast
The average price target for HNST is $7.63, which is 68.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.63 |
| Price Target Difference | 68.81% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNST has an Altman Z-Score of 2.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.84 |
| Piotroski F-Score | 2 |
